Wednesday, TD Cowen began coverage on Axon Enterprise (NASDAQ:AXON) shares, assigning a Buy rating and setting a price target of $700. The firm's analyst, Andrew Sherman, cited Axon's solid position in the public safety market and a robust market share bolstered by durable competitive advantages.
Sherman's positive outlook is supported by feedback from customer checks, which were notably optimistic. According to InvestingPro data, Axon has demonstrated remarkable performance with a 123% return over the past year and maintains a "GOOD" financial health rating, supported by strong gross profit margins of nearly 60%.
Sherman highlighted several key factors that contribute to Axon's strong market position. These include the anticipated success of the TASER 10 and Body 4 product cycles, the potential boost from artificial intelligence advancements, and an expectation of robust bookings in the fourth quarter.
Additionally, Sherman pointed to conservative estimates for fiscal year 2025, emphasizing Axon's history of exceeding expectations and raising forecasts. InvestingPro analysis reveals impressive revenue growth of 32% in the last twelve months, with 13 analysts recently revising their earnings expectations upward.
The analyst also praised Axon's management team for its effectiveness. This leadership, combined with the company's track record, underpins Sherman's confidence in the sustainability of Axon's premium valuation in the market.
In his analysis, Sherman elaborated on the company's competitive edge, stating, "AXON has built an ecosystem for public safety & enjoys high market share with durable competitive advantages." He also mentioned that the company's strong management and consistent performance in beating and raising targets justify the premium valuation he believes will continue.
TD Cowen's initiation of coverage on Axon Enterprise with a bullish stance reflects an expectation of the company's continued success and growth in its sector, backed by innovative products and a capable management team. Sherman's $700 price target suggests a significant upside from the current trading levels of Axon's stock on the NASDAQ.
While analyst targets range from $385 to $800, InvestingPro subscribers can access over 20 additional investment tips and a comprehensive Pro Research Report, offering deeper insights into Axon's valuation metrics and growth potential.
In other recent news, Axon Enterprise has been the subject of multiple analyst evaluations. Raymond (NS:RYMD) James analyst Brian Gesuale upgraded the price target for Axon to $645, viewing the recent 20% stock correction as a buying opportunity.
Gesuale anticipates Axon's cloud revenue to reach $1.5 billion by 2026, which is $103 million higher than his previous model. On a similar note, Baird increased its stock price target for Axon to $800, underlining the company's growth prospects in artificial intelligence (AI).
Meanwhile, Morgan Stanley (NYSE:MS) upgraded Axon's stock from Equalweight to Overweight and increased the price target to $700. The upgrade reflects confidence in the sustainability of the company's growth rate, attributed to robust police tech budgets and Axon's competitive edge in AI solutions. However, defense shares, including Axon, experienced a decline following potential ceasefire reports between Israel and Hezbollah.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.